LB Phase 2a study and baseline data from the RewinD-LB Phase 2b study to be featured in late-breaking oral presentations at CTADBOSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CRVO), a ...

New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing ...

From Brioni and Blazé Milano to Kiton and Massimo Alba, here are seven takes on sartorial looks — one for every day of the ...

The educational event was co-hosted by Vitro Architectural Glass. During the visit Vitro provided the guests with two of its ...

There’ll be over 30 virtual panels, presentations and performances throughout the month designed to uplift and inspire trans ...

For less than $20, Microsoft Visio offers diagramming tools like shapes, premade templates, and stencils to make your next ...

The lunch event (catered by Ozark Catering) featured a 10-minute presentation by Thrasher on her work at Immerse, including research on the growth and continued projected growth of the use of VR in ...

In 2019, Mereo BioPharma completed the Phase 2b dose-finding study (ASTEROID) for setrusumab in 112 adults with OI. The ASTEROID study demonstrated treatment with setrusumab resulted in a clear, ...

The Ithaca College Student Governance Council held its platform presentations Sept. 12 for candidates running in the Fall ...

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

Presentations can be quite stressful. In the middle of it all, you are usually juggling your slides, speaker notes, timing, ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the ...